ISO 26825-2020 pdf download.Anaesthetic and respiratory equipment一User-applied labels for syringes containing drugs used during anaesthesia一Colours, design and performance.
5.4.2 The height of the letters used for the drug name should be as large as possible and shall be not less than 2,5 mm in a plain (sans serif) font with approximately similar proportions of line and space in the letters (i.e. bold or semi-bold style). Either of the following forms of presentation shall be used:
a) lower case letters with an initial upper case letter;
b) lower case letters with the distinguishing parts of similar drug names in upper case letters (known as taIl-man lettering)
All upper case lettering shall not be used.
NOTE 1 When ‘tall-man lettering is applied. see recommendations in Reference Ill and see Table 1. Example No. 12.
NOTE 2 See Clause 6 for non-Roman alphabets.
Different letter sizes can be used:
— for drug names with many letters (e.g. Calciumgluconate) in order to increase readability of more important parts of the name;
— for drugs that are used in different concentrations (e.g. SUFentanil 5 .tg/ml and 25 pg/mI). Check conformity by visual inspection and measurement.
5.4.3 The name of the drug shall be printed on the upper half of the label to allow space for the drug concentration to be written or printed in the lower half.
Check conformity by visual inspection.
5.4.4 For drugs of opposite action (including antagonists), at least the upper 20 % of the width of the label shall be marked with diagonal stripes (see Table 1, Examples No. 4, 8, 11, 13 and 16). The diagonal stripes of each side of the drug name shall take up at least 15 % of the length of the label. The top of the drug name shall be separated from the diagonal stripes by at least 0,5 mm.
Relaxant reversal drugs should be made more discernible from all other drugs of opposite action and antagonists by the addition of a transverse black line below the drug name (see Table 1. Example No. 11). The black line should be 1 mm thick and limited to the width of the drug name.
Check conformity by visual inspection.
5.4.5 All letters shall be black except for
a) the labels for suxamethonium and adrenaline, which shall have bold white lettering for the drug name within a black bar running from edge to edge of the upper half of the label, the rest of which shall display the coloured background (see Table 1. Examples No. 9 and 14);
b) the label for benzodiazepines, which shall have bold white lettering for the drug name alone (see Table 1. Example No. 3).
Check conformity by visual inspection.
5.4.6 Labels for heparin shall have a white background and a black border of width between 1 mm and 2 mm. Labels for protamine shall have a black background with white diagonal stripes as described in 522 and AA (see Table 1. Examples No. 7 and 8).
Check conformity by visual inspection.ISO 26825 pdf download.